Bellicum Pharmacuticals Inc: Falls on stock offering
16/04/2018 21:58
** Drug developer's shares BLCM.O fall 9.70 pct t0 $8.10
in after-market trading
** Stock top pct loser among U.S. listed stocks in extended
trading
** Says commences public offering of 7 mln shares of common
stock; price not disclosed urn:newsml:reuters.com:*:nGNX7SrjML
** Citigroup and Jefferies LLC are the lead book-running
managers for the offering
** Co had 33.57 mln shares outstanding as of April 13 - TR
data
** Up to Monday's close, stock had risen ~7 pct this year
(Reporting by Akankshita Mukhopadhyay in Bengaluru)
((Akankshita.Mukhopadhyay@thomsonreuters.com))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview